Silk fibroin-based embolic agent for transhepatic artery embolization with multiple therapeutic potentials
Open Access
- 19 August 2023
- journal article
- research article
- Published by Springer Nature in Journal of Nanobiotechnology
- Vol. 21 (1) , 1-15
Abstract
Background: The excellent physicochemical and biomedical properties make silk fibroin (SF) suitable for the development of biomedical materials. In this research, the silk fibroin microspheres (SFMS) were customized in two size ranges, and then carried gold nanoparticles or doxorubicin to evaluate the performance of drug loading and releasing. Embolization efficiency was evaluated in rat caudal artery and rabbit auricular artery, and the in vivo distribution of iodinated SFMS (125I/131I-SFMS) after embolization of rat hepatic artery was dynamically recorded by SPECT. Transhepatic arterial radioembolization (TARE) with 131I-SFMS was performed on rat models with liver cancer. The whole procedure of selective internal radiation was recorded with SPECT/CT, and the therapeutic effects were evaluated with 18 F-FDG PET/CT. Lastly, the enzymatic degradation was recorded and followed with the evaluation of particle size on clearance of sub-micron silk fibroin. Results: SFMS were of smooth surface and regular shape with pervasive pores on the surface and inside the microspheres, and of suitable size range for TAE. Drug-loading functionalized SFMS with chemotherapy or radio-sensitization, and the enhanced therapeutic effects were proved in treating HUH-7 cells as lasting doxorubicin release or more lethal radiation. For artery embolization, SFMS effectively blocked the blood supply; when 131I-SFMS serving as the embolic agent, the good labeling stability and embolization performance guaranteed the favorable therapeutic effects in treating in situ liver tumor. At the 5th day post TARE with 37 MBq/3 mg 131I-SFMS per mice, tumor activity was quickly inhibited to a comparable glucose metabolism level with surrounding normal liver. More importantly, for the fragments of biodegradable SFMS, smaller sized SF (< 800 nm) metabolized in gastrointestinal tract and excreted by the urinary system, while SF (> 800 nm) entered the liver within 72 h for further metabolism. Conclusion: The feasibility of SFMS as degradable TARE agent for liver cancer was primarily proved as providing multiple therapeutic potentials. GraphicalKeywords
Funding Information
- National Natural Science Foundation of China (81871390)
- the First Affiliated Hospital of Naval Medical University (Shanghai Changhai Hospital) “Guhai Plan in the 14th Five-Year Plan period” (GH145-22)
- “Discipline Construction Climbing 234 Plan” of Shanghai Changhai Hospital of Naval Medical University (2020YPT002)
This publication has 33 references indexed in Scilit:
- Degradable Starch Microspheres versus Ethiodol and Doxorubicin in Transarterial Chemoembolization of Hepatocellular CarcinomaJournal of Vascular and Interventional Radiology, 2014
- Feasibility of temporary protective embolization of normal liver tissue using degradable starch microspheres during radioembolization of liver tumoursEuropean Journal of Nuclear Medicine and Molecular Imaging, 2013
- In vitro and in vivo evaluation of biodegradable embolic microspheres with tunable anticancer drug releaseActa Biomaterialia, 2013
- Silk fibroin biomaterials for tissue regenerationsAdvanced Drug Delivery Reviews, 2013
- Yttrium 90 radioembolization for the treatment of hepatocellular carcinoma: Biological lessons, current challenges, and clinical perspectivesHepatology, 2013
- Transarterial chemoembolization of hepatocellular carcinoma. Agents and drugs: an overview. Part 1Expert Opinion on Drug Delivery, 2013
- Antibiotic‐Releasing Silk Biomaterials for Infection Prevention and TreatmentAdvanced Functional Materials, 2012
- New Opportunities for an Ancient MaterialScience, 2010
- Transarterial Chemoembolization, Transarterial Chemotherapy, and Intra-arterial Chemotherapy for Hepatocellular Carcinoma TreatmentSeminars in Oncology, 2010
- Biomedical applications of chemically-modified silk fibroinJournal of Materials Chemistry, 2009